After announcing on July 20, 2023, the signing of a letter of intent for a potential merger with Vistacare Medical, subject to satisfactory due diligence audits, Quantum Genomics (Euronext Growth ...
Quantum Genomics is a France-based biopharmaceutical company that develops and commercializes APA inhibitor drugs for the treatment of arterial hypertension and heart failure.